The government has extended restrictions on all fixed dose combinations (FDCs) containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride, mandating a warning that these medicines shall not be used in children below four years. This decision under Section 26A of the Drugs and Cosmetics Act, 1940, follows expert committee and DTAB recommendations to safeguard young children from potential risks.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›Date of Notification: August 22, 2026
- ›Prohibited Age Group: Children below 4 years
- ›Target this Data: Children below 4 years (age restriction)
- ›Target this Nodal Body: Drugs Technical Advisory Board (DTAB)
- ›Target this Legal Point: Section 26A of the Drugs and Cosmetics Act, 1940
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.